Human heart-type fatty acid-binding protein as an early diagnostic marker of doxorubicin cardiac toxicity
Progressive cardiotoxicity following treatment with doxorubicin-based chemotherapy in patients with non-Hodgkin's lymphoma (NHL) may lead to late onset cardiomyopathy. So, early prediction of toxicity can lead to prevention of heart failure in these patients. The aim of this work was to investi...
Main Authors: | ElGhandour, Ashraf H., Sorady, Manal El, Azab, Sahar, ElRahman, Mohammed |
---|---|
Format: | Online |
Language: | English |
Published: |
PAGEPress Publications
2009
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222245/ |
Similar Items
-
CEO role in adult education plans with a hint on adult education plan in Saudi Arabia
by: Abd ElRahman Saad ElHmedy
Published: (1977-01-01) -
Heart-type fatty acid-binding protein as a predictor of cardiac ischemia in intractable seizures in children
by: El Shorbagy, Hatem H., et al.
Published: (2016) -
Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia
by: El-Ansary, Afaf K, et al.
Published: (2011) -
Different Effects of Resveratrol on Dose-Related Doxorubicin-Induced Heart and Liver Toxicity
by: Dudka, Jaroslaw, et al.
Published: (2012) -
Overexpression of Nrdp1 in the Heart Exacerbates Doxorubicin-Induced Cardiac Dysfunction in Mice
by: Zhang, Yuan, et al.
Published: (2011)